Home > Topics > Newer Drugs Approved by FDA in 2012

Newer Drugs Approved by FDA in 2012

August 16, 2012

Vismodegib: T/t of basal cell carcinoma
Ingenol mebutate: T/t of actinic keratosis
Sklice (ivermectin) lotion; Treatment of head lice
Bio-T-Gel (testosterone gel): For the treatment of hypogonadism,
Linagliptin + Metformin: T/t of type II diabetes
Mifepristone: Control of hyperglycemia in adults with endogenous Cushing’s syndrome
Pancrelipase: T/t of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions
Taliglucerase alfa: T/t of Gaucher disease
Peginesatide: T/t of anemia due to chronic kidney disease
Beclomethasone dipropionate nasal aerosol: T/t of seasonal and perennial allergic rhinitis
Rotigotine Transdermal System: T/t of Restless Legs Syndrome
Avanafil: T/t of erectile dysfunction
Pazopanib: T/t of soft tissue sarcoma
Everolimus: T/t of renal angiomyolipoma associated with tuberous sclerosis complex
Axitinib: T/t of advanced renal cell carcinoma
Glucarpidase: T/t of toxic plasma methotrexate concentrations in patients with impaired renal function
Fentanyl sublingual spray: For the treatment of breakthrough cancer pain
Estradiol valerate/dienogest: T/t of heavy menstrual bleeding
Tafluprost ophthalmic solution:For the treatment of elevated intraocular pressure
Surfaxin (lucinactant): T/t of respiratory distress syndrome in premature infants
Kalydeco (ivacaftor); Vertex Pharmaceuticals; For the treatment of cystic fibrosis with the G551D mutation in the CFTR gene, Approved January of 2012

Advertisements
Categories: Topics
%d bloggers like this: